Actinium Pharmaceuticals (ATNM) P/E (2014 - 2026)
Actinium Pharmaceuticals (ATNM) P/E from Mar 31, 2014 to Jul 21, 2026. The TTM Actinium Pharmaceuticals (ATNM) P/E is -1.21. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Actinium Pharmaceuticals (ATNM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.21 | -2.99% |
| 2025 | -1.25 | +24.24% |
| 2024 | -1.01 | -62.50% |
| 2023 | -2.69 | -67.67% |
| 2022 | -8.31 | +61.46% |
| 2021 | -5.15 | +38.34% |
| 2020 | -3.72 | +150.54% |
| 2019 | -1.49 | -18.72% |
| 2018 | -1.83 | +26.86% |
| 2017 | -1.44 | -13.57% |
| 2016 | -1.67 | -73.51% |
| 2015 | -6.29 | -2.46% |
| 2014 | -6.45 | N/A |
Comparison Actinium Pharmaceuticals (ATNM) P/E with competitors
Actinium Pharmaceuticals (ATNM) P/E is -1.21.